The physiology and pathophysiology of rapamycin resistance: implications for cancer
about
Advances in targeting signal transduction pathwaysmTOR-independent 4E-BP1 phosphorylation is associated with cancer resistance to mTOR kinase inhibitors.Hepatic signaling by the mechanistic target of rapamycin complex 2 (mTORC2)Effect of mTOR inhibitors in nude mice with endometrial carcinoma and variable PTEN expression status.Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance.PP242 suppresses cell proliferation, metastasis, and angiogenesis of gastric cancer through inhibition of the PI3K/AKT/mTOR pathwayAdaptation of HepG2 cells to a steady-state reduction in the content of protein phosphatase 6 (PP6) catalytic subunitProfiling of the fetal and adult rat liver transcriptome and translatome reveals discordant regulation by the mechanistic target of rapamycin (mTOR)Hsp90 inhibitors and drug resistance in cancer: the potential benefits of combination therapies of Hsp90 inhibitors and other anti-cancer drugsAnswering the ultimate question "what is the proximal cause of aging?"Recent discoveries in the cycling, growing and aging of the p53 fieldMechanistic or mammalian target of rapamycin (mTOR) may determine robustness in young male mice at the cost of accelerated aging.Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response.Recent progress in genetics of aging, senescence and longevity: focusing on cancer-related genes.Common drugs and treatments for cancer and age-related diseases: revitalizing answers to NCI's provocative questions.Dual mTORC1/2 Inhibition as a Novel Strategy for the Resensitization and Treatment of Platinum-Resistant Ovarian CancerTranslational control of cell fate: from integration of environmental signals to breaching anticancer defense.Targeting PI3K/AKT/mTOR network for treatment of leukemia.Stability of histone post-translational modifications in samples derived from liver tissue and primary hepatic cells
P2860
Q27686983-7D8E361E-CEAB-4219-849D-DBEBE6C82E11Q27851707-CBD511D2-74AA-4AFF-90DD-F5385381348FQ28299373-B44D7122-884E-400B-85E8-4856F40DE8F8Q34306540-4CCA7560-1D66-4D28-A983-CDD2B0EBFCEEQ34307356-3B6E458B-57ED-4D4D-9B97-E18EF3FAD054Q34465116-5CA2253F-ACAE-4181-9054-9CD90684D211Q35798066-FA68B7BA-49FD-43D4-B596-366BD8825638Q35817942-88AED0B8-093C-4416-8E4A-7EDBB454F190Q35823157-C4E2093E-A6EF-48CD-90BA-6A8969379D76Q36736351-50308AA1-7AFF-4885-9B58-97743C14D341Q36736358-C148A929-AD2E-4398-BC34-552DC050F440Q36736362-0CB2FA86-02A5-46C7-BA58-5264C9E95B19Q36862768-86622C30-5D63-4B32-B02F-C24B09973A53Q36926098-F16FCEA8-E882-4732-995A-86D9C79449D9Q36926148-D13F3F5C-1D81-4447-8538-7E4E33634D93Q37662065-4CC3A770-E1A3-44ED-B5F2-0F70741C106BQ37987280-72629760-6B5C-4BD1-8C96-BF890BB1FD1FQ38364871-E619084C-25D2-4819-9530-32674C4DF533Q58760210-50D6E3F7-160C-42CD-9862-90F56FB5FE23
P2860
The physiology and pathophysiology of rapamycin resistance: implications for cancer
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The physiology and pathophysiology of rapamycin resistance: implications for cancer
@ast
The physiology and pathophysiology of rapamycin resistance: implications for cancer
@en
The physiology and pathophysiology of rapamycin resistance: implications for cancer
@nl
type
label
The physiology and pathophysiology of rapamycin resistance: implications for cancer
@ast
The physiology and pathophysiology of rapamycin resistance: implications for cancer
@en
The physiology and pathophysiology of rapamycin resistance: implications for cancer
@nl
prefLabel
The physiology and pathophysiology of rapamycin resistance: implications for cancer
@ast
The physiology and pathophysiology of rapamycin resistance: implications for cancer
@en
The physiology and pathophysiology of rapamycin resistance: implications for cancer
@nl
P2093
P2860
P356
P1433
P1476
The physiology and pathophysiology of rapamycin resistance: implications for cancer
@en
P2093
Jennifer A Sanders
Joan M Boylan
Philip A Gruppuso
P2860
P304
P356
10.4161/CC.10.7.15230
P407
P577
2011-04-01T00:00:00Z